Madelung's disease is characterized by the manifestation of multiple ectopic lipomas, usually found in the cervical-thoracic region, however, clinical manifestation may vary among patients.
It has been postulated that lipomas associated with Madelung's disease are linked to brown adipose tissue (BAT) due to the presence of uncoupling protein 1 (UCP1). Therefore, we here investigated whether BAT activity is present in a patient with Madelung's disease. Madelung's disease mainly affects males and is associated with alcohol abuse early in life. [2] [3] [4] Clinically, patients can be divided in two subgroups: Type 1, with symmetrical gross masses in the upper part of the body and Type 2, with more general obesity. Uncoupling protein 1 (UCP1) has been detected in biopsies taken from lipomas in patients suffering from Madelung's disease. 6 Normally, mitochondria build up a proton gradient across the membrane by oxidation of substrates which is used to produce ATP. Adrenergic activation of UCP1 uncouples this process resulting in heat production instead of ATP production. 7 UCP1 is normally specific for brown adipose tissue (BAT), which could mean that BAT is present in the lipomas. However, cells derived from these lipomas do not respond to adrenergic receptor stimulated lipolysis, 6 and this may indicate reduced fatty acid availability and related disturbed BAT metabolism. This would impair mitochondrial uncoupling and BAT thermogenesis, potentially reducing the body's protection against cold together with an elevated sympathetic nervous system activity. This could in turn lead to proliferation of adipocytes. 6 In other samples taken from lipomas there was also evidence for mitochondrial dysfunction due to mutations in the mitochondrial DNA. The patient had not used beta-blockers in the last year.
BAT presence and activity was determined in the patient using an individualized cooling procedure and were either paraffin-embedded or frozen in melting isopentane prior to further analysis. RNA was extracted using Trizol reagent followed by protocol described in the RNeasy kit from Qiagen (Hildenberg, In line with the 18 F-FDG-PET/CT results, both adipose tissue biopsies showed a typical morphology of WAT (Figures 2 and 3) , which was negative for UCP1 mRNA. However, it is possible that our patient has another causal mechanism, explaining the lack of UCP1. 5, 6, 8 This could potentially explain why we were unable to find any sign of BAT presence in the biopsy material.
The use of an 18 F-FDG-PET/CT scan combined with the cooling procedure is an established method to detect the presence of active BAT. 9 Generally, the prevalence is highest in young healthy (lean) adults, although BAT is not always detected in all lean subjects. 10 The prevalence of BAT decreases with obesity and age. 9 In view of the age and BMI of our patient, this may also explain the absence of active BAT.
The defective adrenergic pathway in Madelung's disease could also explain the absence of tracer uptake in both upper arms. In the adipose tissue biopsies, we only found cells resembling white adipocytes without any expression of UCP1 mRNA. An in vitro model with primary cultured adipocytes derived from patient adipose tissue could be used to examine UCP1 expression after adrenergic stimulation.
However, these experiments would require freshly isolated adipose tissue biopsies.
Concluding, in a patient with clinical Madelung's disease we found no active BAT, neither in the lipomas nor in the cervicalthoracic region. However, since this was a single case, the results in patients may differ, and this may not exclude BAT activity in other patients. Further research could focus on the causal mechanism for Madelung's disease and the possible relationship with BAT.
